Patents by Inventor Mika Goto

Mika Goto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANNABINOID RECEPTOR MODULATOR
    Publication number: 20100240743
    Abstract: A cannabinoid receptor modulator containing a compound represented by Formula (I0) wherein, X is an oxygen atom, etc., R0 is an optionally substituted acylamino group, ring A0 is a benzene ring which may further have a substituent in addition to R0, and ring B is an optionally substituted 5-membered heterocycle, or a salt thereof or a prodrug thereof.
    Type: Application
    Filed: April 8, 2010
    Publication date: September 23, 2010
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Shigenori OHKAWA, Tetsuya Tsukamoto, Yoshihiro Kiyota, Mika Goto, Shouzou Yamamoto, Masato Shimojou, Masaki Setou
  • Ligand to GPR8
    Patent number: 7671174
    Abstract: The present invention provides a ligand to GPR8, in particular polypeptides capable of binding to GPR8 or its amides or esters, or salts thereof, as well as the DNA encoding for such polypeptides. The ligand to GPR8 of the present invention is useful in developing receptor-binding assay systems with the use of a GPR8 expression system, for screening candidate compounds for drugs such as preventive/therapeutic agents for obesity, appetite stimulants, and prolactin production inhibitors.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: March 2, 2010
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masaaki Mori, Yukio Shimomura, Mioko Harada, Taiji Asami, Yoshio Matsumoto, Yuka Adachi, Tsukasa Sugo, Michiko Abe, Mika Goto, Chieko Kitada, Takuya Watanabe
  • Cannabinoid receptor modulator
    Patent number: 7507841
    Abstract: A cannabinoid receptor modulator containing a compound represented by Formula (I0) wherein, X is an oxygen atom, etc., R0 is an optionally substituted acylamino group, ring A0 is a benzene ring which may further have a substituent in addition to R0, and ring B is an optionally substituted 5-membered heterocycle, or a salt thereof or a prodrug thereof.
    Type: Grant
    Filed: July 11, 2007
    Date of Patent: March 24, 2009
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shigenori Ohkawa, Tetsuya Tsukamoto, Yoshihiro Kiyota, Mika Goto, Shouzou Yamamoto, Masato Shimojou, Masaki Setou
  • Cannabinoid receptor modulator
    Publication number: 20090023800
    Abstract: A cannabinoid receptor modulator containing a compound represented by Formula (I0) wherein, X is an oxygen atom, etc., R0 is an optionally substituted acylamino group, ring A0 is a benzene ring which may further have a substituent in addition to R0, and ring B is an optionally substituted 5-membered heterocycle, or a salt thereof or a prodrug thereof.
    Type: Application
    Filed: August 29, 2008
    Publication date: January 22, 2009
    Inventors: Shigenori Ohkawa, Tetsuya Tsukamoto, Yoshihiro Kiyota, Mika Goto, Shouzou Yamamoto, Masato Shimojou, Masaki Setou
  • Cannabinoid receptor modulator
    Patent number: 7465815
    Abstract: A cannabinoid receptor modulator containing a compound represented by Formula (I0) wherein, X is an oxygen atom, etc., R0 is an optionally substituted acylamino group, ring A0 is a benzene ring which may further have a substituent in addition to R0, and ring B is an optionally substituted 5-membered heterocycle, or a salt thereof or a prodrug thereof.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: December 16, 2008
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shigenori Ohkawa, Tetsuya Tsukamoto, Yoshihiro Kiyota, Mika Goto, Shouzou Yamamoto, Masato Shimojou, Masaki Setou
  • Ligand to GPR8 and DNA thereof
    Publication number: 20080305998
    Abstract: The present invention aims at providing a ligand to GPR8, its DNA, etc., and more particularly, a polypeptide capable of binding to GPR8 or its amides or esters, or salts thereof, as well as its DNA, etc. The ligand to GPR8 of the present invention is useful in developing a receptor-binding assay system with the use of a GPR8 expression system, screening candidate compounds for drugs such as preventive/therapeutic agents for obesity, appetite stimulants, prolactin production inhibitors, etc.
    Type: Application
    Filed: January 26, 2007
    Publication date: December 11, 2008
    Inventors: Masaaki Mori, Yukio Shimomura, Mioko Harada, Taiji Asami, Yoshio Matsumoto, Yuka Adachi, Tsukasa Sugo, Michiko Abe, Mika Goto nee Mika Kurihara, Chieko Kitada, Takuya Watanabe
  • Cannabinoid receptor modulator
    Publication number: 20080021087
    Abstract: A cannabinoid receptor modulator containing a compound represented by Formula (I0) wherein, X is an oxygen atom, etc., R0 is an optionally substituted acylamino group, ring A0 is a benzene ring which may further have a substituent in addition to R0, and ring B is an optionally substituted 5-membered heterocycle, or a salt thereof or a prodrug thereof.
    Type: Application
    Filed: July 11, 2007
    Publication date: January 24, 2008
    Inventors: Shigenori Ohkawa, Tetsuya Tsukamoto, Yoshihiro Kiyota, Mika Goto, Shouzou Yamamoto, Masato Shimojou, Masaki Setou
  • Method of screening preventives or remedies for obesity
    Patent number: 7247440
    Abstract: The present invention provides preventive/therapeutic agents for anorexia nervosa and preventive/therapeutic agents for obesity. More specifically, the present invention provides a method and kit for screening a compound or its salt that changes the binding properties of GPR7 to a polypeptide capable of binding specifically to GPR7.
    Type: Grant
    Filed: May 14, 2002
    Date of Patent: July 24, 2007
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masaaki Mori, Yukio Shimomura, Mika Goto
  • Cannabinoid receptor modulator
    Publication number: 20070099990
    Abstract: A cannabinoid receptor modulator containing a compound represented by Formula (I0) wherein, X is an oxygen atom, etc., R0 is an optionally substituted acylamino group, ring A0 is a benzene ring which may further have a substituent in addition to R0, and ring B is an optionally substituted 5-membered heterocycle, or a salt thereof or a prodrug thereof.
    Type: Application
    Filed: June 25, 2004
    Publication date: May 3, 2007
    Inventors: Shigenori Ohkawa, Tetsuya Tsukamoto, Yoshihiro Kiyota, Mika Goto, Shouzou Yamamoto, Masato Shimojou, Masaki Setou
  • Peptide having appetite stimulating activity
    Patent number: 7193033
    Abstract: The present invention provides a ligand to GPR8, in particular polypeptides capable of binding to GPR8 or its amides or esters, or salts thereof, as well as DNA, encoding for such polypeptides. The ligand to GPR8 of the present invention is useful in developing a receptor-binding assay system with the use of a GPR8 expression system, for screening candidate compounds for drugs such as preventive/therapeutic agents for obesity, appetite stimulants, and prolactin production inhibitors.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: March 20, 2007
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masaaki Mori, Yukio Shimomura, Mioko Harada, Taiji Asami, Yoshio Matsumoto, Yuka Adachi, Tsukasa Sugo, Michiko Abe, Mika Goto, Chieko Kitada, Takuya Watanabe
  • Ligand to gpr8 and dna thereof
    Publication number: 20050153391
    Abstract: The present invention aims at providing a ligand to GPR8, its DNA, etc., and more particularly, a polypeptide capable of binding to GPR8 or its amides or esters, or salts thereof, as well as its DNA, etc. The ligand to GPR8 of the present invention is useful in developing a receptor-binding assay system with the use of a GPR8 expression system, screening candidate compounds for drugs such as preventive/therapeutic agents for obesity, appetite stimulants, prolactin production inhibitors, etc.
    Type: Application
    Filed: June 20, 2001
    Publication date: July 14, 2005
    Inventors: Masaaki Mori, Yukio Shimomura, Mioko Harada, Taiji Asami, Yoshio Matsumoto, Yuka Adachi, Tsukasa Sugo, Michiko Abe, Mika Goto, Chieko Kitada, Takuya Watanabe
  • Screening method
    Publication number: 20040110231
    Abstract: The present invention is intended to provide a preventive/therapeutic agent for anorexia nervosa, a preventive/therapeutic agent for obesity, etc. More specifically, the present invention provides a method/a kit for screening a compound or its salt that changes the binding properties of GPR7 to a polypeptide capable of binding specifically to GPR7, characterized by using GPR7 and the said polypeptide, compounds thus obtained, etc.
    Type: Application
    Filed: November 14, 2003
    Publication date: June 10, 2004
    Inventors: Masaaki Mori, Yukio Shimomura, Mika Goto